120. Once-Weekly Mazdutide in Chinese Adults with Obesity or Overweight.
作者: Linong Ji.;Hongwei Jiang.;Yan Bi.;Hua Li.;Junhang Tian.;Dexue Liu.;Yuzhu Zhao.;Wei Qiu.;Chongbing Huang.;Lei Chen.;Shao Zhong.;Jie Han.;Yawei Zhang.;Qiufang Lian.;Ping Yang.;Lingchun Lv.;Jieyu Gu.;Zihan Liu.;Huan Deng.;Yanqi Wang.;Li Li.;Lijuan Pei.;Lei Qian.; .
来源: N Engl J Med. 2025年392卷22期2215-2225页
Evidence suggests that incretin-based dual agonist pharmacotherapy is helpful in persons with obesity. Mazdutide, a glucagon-like peptide-1 and glucagon receptor dual agonist, may have efficacy in persons with overweight or obesity.
|